MF

Michael Fenn

Head Investor Relations & External Innovation, Dewpoint Therapeutics / Venture Capital / Biomedical Engineer

Greater Boston

VC
Investor

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Cell Culture
Spectroscopy
Nanotechnology
Biomedical Engineering
Microscopy
Nanoparticles
Research
Materials Science
Science
Nanomaterials
Cancer Research
Laboratory
Oncology
Scanning Electron Microscopy
Characterization
FTIR
TEM
UV/Vis
Surface Chemistry
Raman Micro-Spectroscopy

Education

Work Experience

Dewpoint Therapeutics

2021

  • Head Investor Relations & External Innovation - Senior Director

    2021

Iaso Ventures

2022

  • Venture Partner

    2022

Harvard Innovation Labs

2019

  • Innovation Fellow

    2021

  • Director Healthcare & Life Sciences

    2019 - 2021

Harmonix Fund

2020

  • Scientific Advisor

    2020

CytoVeris Inc.

2020

  • Scientific Advisory Board

    2020

NExTNet Inc.

2020

  • Scientific Advisory Board

    2020

Uncommon

2020

  • Scientific Advisory Board

    2020

SciColab Ventures LLC

2010

  • Founder & Principal

    2010

Nexien BioPharma

2018 - 2021

  • Scientific Advisory Board

    2018 - 2021

JointechLabs Inc.

2017 - 2020

  • Scientific Advisory Board

    2017 - 2020